Differences in Endothelin B Receptor Isoforms Expression and Function in Breast Cancer Cells
Meena Halaka, Zuhaila Hired, Grace Rutledge, Carly M. Hedgepath, Michael P. Anderson, Haley St. John, M. Jessica, Parth R. Majmudar, Caleb Walker, Asma Alawawdeh, Hannah Stephen, Caleb C. Reagor, Jeanette Adereti, Kiara Jamison, Katherine Iglesias, Khadija Kirmani, Rebecca Conway
Abstract
The endothelins and their receptors are best known for their regulation of the vascular system. Their widespread expression in epithelial cells and their overexpression in some tumors has prompted investigation into their ability to regulate cancer progression. In this study, we assessed the mRNA expression of the major endothelin B receptor gene (EDNRB) isoforms and found differences in both mRNA and protein expression in normal breast cells and breast cancer cell lines. Knocking down the EDNRB gene in breast cancer cells altered invasiveness toward endothelin 3 (ET3), and we observed EDNRB isoform-specific regulation of breast cancer cell invasion and cell signaling, as well as isoform- and subtype-specific differences in breast cancer patient survival. The results reported in this study emphasize the importance of the endothelin B receptor in breast cancer. To our knowledge, this study is the first to clarify the differential expression and roles of specific EDNRB isoforms in breast cancer.